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Abstract—Non-Alcoholic Fatty Liver Disease (NAFLD) is be-
coming increasingly prevalent in the world population. Without
diagnosis at the right time, NAFLD can lead to non-alcoholic
steatohepatitis (NASH) and subsequent liver damage. The diagno-
sis and treatment of NAFLD depend on the NAFLD activity score
(NAS) and the liver fibrosis stage, which are usually evaluated
from liver biopsies by pathologists. In this work, we propose a
novel method to automatically predict NAS score and fibrosis
stage from CT data that is non-invasive and inexpensive to
obtain compared with liver biopsy. We also present a method to
combine the information from CT and H&E stained pathology
data to improve the performance of NAS score and fibrosis
stage prediction, when both types of data are available. This
is of great value to assist the pathologists in computer-aided
diagnosis process. Experiments on a 30-patient dataset illustrate
the effectiveness of our method.
Index Terms—NAFLD activity score, Liver fibrosis, Deep
learning.
I. INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) is now the most
common form of chronic liver disease in the world. The preva-
lence of this disease has been estimated to be over 25% in the
general worldwide population [1]. This disease encompasses
a spectrum of changes in the liver related to fat deposition.
The changes range from non-alcoholic fatty liver (NAFL) with
simple steatosis (> 5% liver fat content) with minimal or no
inflammation, to a progressive form of the disease called non-
alcoholic steatohepatitis (NASH). NASH is characterized by
steatosis, inflammation and hepatocellular injury, with eventual
progression to various stages of fibrosis [2]. As the progressive
form of the disease, NASH is associated with increased mor-
bidity and mortality; therefore, determination of this disease is
important during diagnosis. Liver biopsy is the gold standard
for determining the fibrosis stage and diagnosing NASH from
NAFLD activity score (NAS) to differentiate it from simple
steatosis. However, the cost of an invasive procedure such as
* equal contribution
liver biopsy combined with the possibility of complications
such as bleeding, infections, and rarely death, rule out its
routine use in clinical practice [3]. In addition, intra-observer
variance along with sampling variance add significant error to
the manual interpretation of liver biopsy histopathology [4],
[5]. Therefore, it is of great value to develop computational
methods for NAS score prediction and fibrosis staging from
non-invasive imaging modality data. Besides, when the biopsy
data is available, it is meaningful to build computational
models to predict scores from the biopsy data, which can
assist pathologists in the diagnosis process by saving time and
reducing the unreliability of less-experienced doctors.
Recently, deep learning has been immensely successful in
image analytics tasks such as image classification [6] and
semantic segmentation [7]. The ability to learn meaningful
features automatically makes deep learning superior to tradi-
tional machine learning approaches. There have been many
deep learning based works on fibrosis staging and NAS
score prediction. These methods cover various types of data,
such as CT scans [8]–[10], Magnetic Resonance Imaging
(MRI) [11]–[13], pathology images from liver biopsy [14]–
[16] and others [17], [18]. CT and MRI scans are non-invasive,
thus it is beneficial for patients if one can obtain accurate
fibrosis stage and NAS scores from these scans. Compared
with CT and MRI data, pathology images are more informative
about the disease, and are used as gold standard for diagnosis.
For fibrosis staging, Yasaka et al. [8] explored the use of a
deep convolutional neural network (CNN) for staging liver
fibrosis on magnified CT images of the liver surface. They
concatenated the age and sex information of the subject at
one of the fully connected layers. The scores found from the
model were moderately correlated with the liver fibrosis stage
as found from histopathology. Jin et al. [9] proposed a fibrosis
prediction mechanism where the liver region in the image was
first segmented using a segmentation network and then clas-
sified using a CNN. Yu et al. [15] investigated and compared
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Fig. 1. CT data preprocessing and Baseline network structure.
the performance of liver fibrosis stage classification using
different deep learning algorithms and other machine learning
algorithms. Fu et al. [14] explored fibrosis identification with
the help of image segmentation. But their method didn’t
predict the exact fibrosis stage. Heinemann et al. [16] trained a
CNN to predict fibrosis by using histology images at different
scales. For NAS score prediction, pathology data is more often
used. Heinemann et al. [16] trained a CNN to predict the
three individual NAS scores - NAS steatosis, NAS lobular
inflammation, NAS ballooning. NAS score prediction from CT
images has rarely been explored. Hence, an important question
is: can we predict NAS scores directly from CT images?
Besides, when the paired pathology data is also available,
can we utilize both CT and pathology data to improve the
prediction performance? In practice, the diagnoses using CT
scans and pathology slides are performed by radiologists and
pathologists, respectively. If we can combine the information
from both types of doctors (i.e., train a model that collect
information from both types of data), it could be beneficial to
the final results.
In this work, we propose to predict the individual NAS
scores (NAS steatosis, NAS lobular inflammation, NAS bal-
looning) directly from CT images using deep learning. The
3D CT volumes are divided into 2D slices, in which the liver
portion is segmented. Features are extracted from these slices
by a pretrained ResNet [19], and then aggregated by a classifier
for prediction. Besides, we also combine the information
from CT scans and pathology images to further improve
the performance, considering that they may contain different
levels of information about the disease. The CT and pathology
images are fed into two separate networks to produce features
that are related to fibrosis or NAS. Then the two types of
features are fused to get the final classification result. We
explore different feature fusion strategies and loss functions.
The proposed method can achieve a good performance on a
30-patient dataset that contains paired CT and pathology data.
In summary, our main contributions include:
• We propose a novel method to predict NAS scores
directly from CT images.
• We design a network to predict fibrosis stage and NAS
score from CT and pathology images, and we achieve
better performance than any single type of data.
• As far as we know, we are the first to perform deep
learning based NAS score prediction using CT images
and to use multiple-modality data for fibrosis staging and
NAS score prediction.
II. METHOD
The overview of our proposed method is shown in Fig. 1
and Fig. 2. It consists of two main steps: (1) data preprocessing
on CT scans and pathology slides, (2) network training using
the preprocessed data.
A. Data preprocessing
The raw CT and pathology data cannot be directly fed into
CNNs for training. We perform preprocessing for each type
of data.
1) 2D liver segmentation (CT data): The raw CT scans are
3D volumetric data. To be compatible with the 2D pathology
images during training, we extract 2D slices from each 3D
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Fig. 2. Baseline network and four different joint networks.
scan. Hounsfield windowing with the range [−200, 250] is
performed on the 2D CT slices to increase the image contrast.
As we only focus on the liver part in the CT images, we
perform 2D liver segmentation to extract liver regions before
the fibrosis stage and NAS score prediction tasks. All other
pixels are set to zero to avoid the negative effect of other
organs (shown in Fig. 1). The segmentation model is first
pretrained on the ISBI2012 dataset [20]. Then we annotate
a small part of the 2D slices in our dataset and fine-tune
the segmentation model with the annotated images, utilizing
transfer learning. We had made a train test split on the
annotated liver dataset. The dice score of the segmentation
network was 0.9421 on the test liver dataset. After liver
segmentation, the slices with an average pixel value below
a threshold (5 in our experiments) are discarded. This ensures
that slices containing very small liver portions and those slices
which do not contain liver portion at all are discarded. The
number of CT slices after preprocessing is 2595.
2) Patch generation (pathology data): The original pathol-
ogy whole slide images (WSIs) have very high resolution
(10,000 to >100,000 pixels on each dimension). It is im-
practical to put these images into a neural network directly.
Besides, a large portion of pixels in each WSI belong to
background and contain no information. It is better to remove
such background areas during training, otherwise the useful in-
formation from tissue may be overwhelmed by uninformative
pixels. Therefore, we extract non-overlapping image patches
of resolution 224×224 from each WSI at 5× magnification.
Patches that have a mean pixel value greater than 220 are
considered as background and are removed. The number of
pathology patches after preprocessing is 7775.
B. Baseline network for CT images
This network is designed to predict the NAS scores based
on CT data. The architecture, shown in Fig. 1 and Fig. 2(a),
consists of a feature extractor and a classifier. The feature
extractor aims to obtain a feature vector that represents the
input 2D slice. We use the ResNet-18 [19] (without the final
fully-connected layers) as our feature extractor because of two
reasons - (1) the more complex models would overfit our
training data which is limited to 30 patients, (2) the training
is done at patient level, i.e., all the pathology patches and
CT 2D slices are fed to the network for training, making it
hard to use larger models due to GPU memory limitations.
The classifier consists of fully-connected layers and an average
pooling layer. The first two fc layers have 512 and 128 neurons
respectively, which further process the extracted features of all
input CT slices of a patient. The subsequent average pooling
layer is used to obtain the global feature vector from local
feature vectors of 2D slices. The final fc layer predicts the
classification result from the global feature. Each individual
score (fibrosis, NAS steatosis, NAS lobular, NAS ballooning)
is trained with one network.
The baseline network can be also used to predict NAS scores
and fibrosis stage from histpathology images by just replacing
the input 2D slices with the extracted patches from a WSI.
C. Joint network for both data
The structure of the joint network for both CT and pathology
data are shown in Fig. 2. There are two separate baseline
networks and a joint classifier. The two baseline networks take
as input the CT images and the pathology images, respectively.
The joint classifier takes as input the fused features from the
TABLE I
ORIGINAL AND COMBINED FIBROSIS STAGE AND NAS SCORE DISTRIBUTIONS IN THE 30-SUBJECT DATASET.
Fibrosis NAS steatosis NAS lobular NAS ballooning
Score 0 1 2 3 3.5 4 0 1 2 3 0 1 2 3 0 1 2
Original 7 6 4 3 2 8 2 9 11 8 9 10 8 3 8 11 11
Combined 7 10 13 11 19 9 10 11 8 11 11
two baseline networks, and outputs the prediction. We explore
the effects of two different feature fusion strategies and two
types of loss functions, resulting in four different architectures.
1) Mid-fusion vs. late-fusion: In the mid-fusion architec-
tures (Fig. 2(b) and Fig. 2(d)), the outputs of the two baseline
networks’ feature extractors are concatenated and fed to the
joint classifier, which has the same structure as the classifier in
the baseline network. In this case, local features of all 2D CT
slices and pathology patches are stacked together to produce
a global feature representation of both types of data.
In the late-fusion architectures (Fig. 2(c) and Fig. 2(e)), the
fusion is done after the average pooling layers of the two
baseline networks. That’s to say, we concatenate the global
features (1×128 each) obtained from both types of data to
form a single feature (1×256). The fused global feature is
sent to the joint classifier, which consists of a fully connected
layer.
2) Single-loss vs. multi-loss: For the single-loss architec-
tures (Fig. 2(b) and Fig. 2(c)), we only compute the loss with
regard to the output of the joint classifier, i.e., L = Ljoint.
It only cares about whether the prediction from both types of
data is correct or not.
For the multi-loss architectures (Fig. 2(d) and Fig. 2(e)), the
final loss L is the summation of the joint loss and losses from
each individual baseline network, i.e., L = Ljoint + LCT +
Lpatho. It requires all three classifiers (CT, pathology, joint)
to make correct predictions. During testing, the output from
the joint classifier is treated as the final prediction.
III. EXPERIMENTS
A. Dataset and evaluation metrics
1) Dataset: The dataset used in our experiments consists
of CT volumes and H&E stained histopathology whole slide
images of 30 subjects, in particular one CT volume and one
slide image per subject. All data are private data from our
collaborative partner and are de-identified. The ground-truth
fibrosis stage and NAS scores are provided by a pathologist
with manual examination on the WSIs. We randomly split
the 30 patients into three groups and perform 3-fold cross
validation in all experiments.
The fibrosis stage ranges from 0 to 4. The total NAS score
is made up of three individual scores - NAS steatosis, NAS
lobular inflammation and NAS ballooning, which have 4, 4 and
3 different values, respectively. The original score distribution
in the 30 subjects is shown in the Table I.
2) Label generation: The original stage/scores cannot be
used for training because the number of patients in some
stages/scores are too small (e.g., 3 patients in fibrosis stage 3, 2
patients in NAS steatosis score 0). Based on our collaborating
clinical doctor’s input, we divide the fibrosis stages into three
classes, NAS steatosis scores into two classes, NAS lobular
into three classes and NAS ballooning into three classes.
The distribution of the new classes are shown in Table 1
(‘Combined’ row). In each combined class, there are relatively
enough data for training.
3) Evaluation metrics: We use the Area Under ROC Curve
(AUC) to evaluate the classification performance in our ex-
periments. The ROC curve is created by plotting the true
positive rate (TPR) against the false positive rate (FPR) at
various threshold settings. AUC tells how much a model
is capable of distinguishing between two classes. We also
compute the 95% confidence interval for AUC using the
bootstrapping method with 1000 iterations. For the two-class
problem (NAS steatosis), AUC values are averaged over the
three folds to give the mean AUC. For the three-class problems
(NAS lobular, NAS ballooning and fibrosis), the AUC value
of each individual class is computed by treating the other two
classes as one class. The AUC of each fold is the average of
AUC values of the three classes. The final mean AUC of an
experiment is the average of three folds.
B. Implementation Details
We implement our method using the PyTorch [21] library.
During training, the ResNet-18 without fc layer (the feature
extractor) is initialized with pretrained weights from Ima-
geNet [22]. To avoid overfitting, only the last residual block
is updated. For all experiments, the models are trained with
the Adam optimizer for 30 epochs. The learning rate, batch
size and weight decay are 0.0001, 4 and 0.01, respectively.
The best model of the 30 epochs is selected for test. We have
used the cross entropy loss in our experiments.
C. Results and discussion
For each of the four prediction experiments (NAS steatosis,
NAS lobular, NAS ballooning, fibrosis), we report the results
using single type of data (CT or pathology), and both types
of data on the four different architectures: mid-fusion with
single loss, late-fusion with single loss, mid-fusion with multi-
loss, late-fusion with multi-loss. The results are shown in
Table II and Fig. 3. We also compare our method with a
latest related work [16]. In that work, Inception-V3 (pretrained
on ImageNet) backbone network is used to predict fibrosis
and NASH score from rat/mouse liver pathology images. The
results of their method on our data are shown in Table II.
1) Comparison of results using single modality data:
When using only CT data, our baseline method can predict
the fibrosis stage with 76.35 AUC score, but the results of
TABLE II
MEAN AUC VALUES OF FIBROSIS STAGE AND NAS SCORES PREDICTION USING DIFFERENT METHODS (THREE-FOLD CROSS VALIDATION).
Method Fibrosis NAS steatosis NAS lobular NAS ballooning
CT 76.35±15.77 67.88±8.85 61.82±14.19 64.38±16.29
H&E 83.85±9.68 94.04±10.33 64.85±4.8 74.63±17.19
Mid-fusion Single-loss 89.84±7.92 95.95±7.02 74.46±6.4 77.19±13.36
Mid-fusion Multi-loss 85.74±11.83 92.10±10.35 64.89±4.12 72.11±12.43
Late-fusion Single-loss 86.29±4.23 91.12±3.51 65.83±5.13 73.78±20.89
Late-fusion Multi-loss 83.74±8.91 85.06±15.8 64.54±15.06 66.18±20.11
Simulation of Heinemann et al [16] 59.06±10.11 66.33±9.45 62.33±3.5 55.26±5.46
(a) Fibrosis (b) NAS steatosis
(c) NAS lobular (d) NAS ballooning
Fig. 3. AUC values and 95% confidence intervals for different folds.
NAS scores predictions are not good enough (AUC 61.82-
67.88). The lobular imflammation and the ballooning are
both microscopic structures, which are often analyzed in the
pathology images. Therefore, using H&E slides demonstrate
a higher performance score than using CT. Actually, H&E
outperforms CT on all four tasks, because H&E images have
more details about the cell and tissue structure.
2) Comparison of results using multi-modality data: The
multi-modality based architecture (Mid-fusion with single-
loss) achieves better results than any of the single modality
(CT or H&E) based architecture. The mean AUC values on
fibrosis, NAS lobular, NAS ballooning are better than those
in single modality. The NAS steatosis result is similar as
that of H&E because they are pretty high, and the room
for improvement is limited. As for NAS lobular and NAS
ballooning, the fused model can learn some useful features
from CT data, although it is hard for diagnostic radiologists to
find them in CT data. These results prove that the combination
of CT and pathology data is indeed beneficial to train a more
robust model.
a) Mid-fusion VS. late-fusion: The results using mid-
fusion strategy are better than those of late-fusion for both
types of loss functions. Mid-fusion gathers the local features
from each type of data while late-fusion combines the global
features. The local features have more information about the
images than global features, which could be the reason that
mid-fusion works better than late-fusion.
b) Single-loss VS. multi-loss: Whatever the feature fu-
sion strategy is, single-loss achieves higher AUC value than
multi-loss, indicating that the learning of single modality
branches may have negative effects on the joint classifier. The
overall performance may be improved if we use a more so-
phisticated method to adjust the weights of different branches.
This is a topic of future work.
3) Comparison to the latest related work: As we can see
from the table, Heinemann’s [16] work performs worse on
our dataset for both fibrosis and NASH scoring. One of the
reasons for the poor performance of Heinemann’s work on our
dataset could be due to the slightly different scoring procedure
used in their work. Heinemann’s work gives individual class
labels to each patch from a single WSI slide which means
two different patches from the same WSI slide can potentially
get two completely different class labels. Secondly, the rule
to determine the fibrosis and NASH score of a patch also
varies slightly from the macroscopic scoring. An example is
the scoring of NASH ballooning where scores are given based
on the rule - if the patch does not have a ballooning cell
then its class label is 0, else the class label is 1 which is
a little different from the macroscopic scoring where classes
are assigned based on the presence of (1) None (2) Few or
(3) Many ballooning cells. In our work, we have patient level
fibrosis and NASH scores. All the patches from a patient have
the same fibrosis and NASH score as the patient’s WSI slide.
IV. CONCLUSION AND FUTURE WORK
This work explores the use of deep learning techniques
to predict NAS scores directly from CT images, and to
combine data from two different modalities for improving
the estimation of fibrosis stage and the prediction of NAS
score. Based on our positive results, in the future we plan to
explore how this method scales when using more than two
categories of data and also how it performs with other types
of data, e.g., ultra sonograpy, MRI, MRE. It will be better
for clinical applications if we can increase performance using
several types of non-invasive imaging data, such as CT and
MRI. We also plan future research on how the weights of
different losses will affect the final prediction result.
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